|Bid||21.45 x 3100|
|Ask||21.53 x 3200|
|Day's Range||21.38 - 21.63|
|52 Week Range||15.25 - 21.63|
|Beta (3Y Monthly)||0.54|
|PE Ratio (TTM)||26.80|
|Earnings Date||Feb 5, 2020 - Feb 10, 2020|
|Forward Dividend & Yield||1.04 (4.86%)|
|1y Target Est||21.88|
Medical Properties Trust, Inc. announced today that its Board of Directors declared a quarterly cash dividend of $0.26 per share of common stock to be paid on January 9, 2020, to stockholders of record on December 12, 2019.
Medical Properties Trust, Inc. (the “Company”) (MPW) announced today the pricing of its previously announced public offering of sterling-denominated notes, to be issued by its operating partnership, MPT Operating Partnership, L.P. (the “Operating Partnership”), and MPT Finance Corporation, a wholly-owned subsidiary of the Operating Partnership (“MPT Finance” and, together with the Operating Partnership, the “Issuers”). The Notes will be senior unsecured obligations of the Issuers, guaranteed by the Company. The Issuers estimate that the net proceeds from the offering will be approximately £993.0 million ($1.22 billion).
Medical Properties Trust, Inc. (the “Company”) (MPW) announced today that its operating partnership, MPT Operating Partnership, L.P. (the “Operating Partnership”), and MPT Finance Corporation, a wholly-owned subsidiary of the Operating Partnership (“MPT Finance” and, together with the Operating Partnership, the “Issuers”), intend to commence a benchmark offering of senior notes (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of the Issuers, guaranteed by the Company. The Issuers intend to use approximately £367.0 million ($0.5 billion) of the net proceeds from the offering to repay amounts outstanding under the revolving credit facility of the Operating Partnership, and the remaining net proceeds for general corporate purposes, which may include working capital, capital expenditures and potential future acquisitions.
One strategy: Have 80% of a portfolio in stocks, including higher-yielding master limited partnerships and real estate investment trusts, with the remaining 20% in fixed income and preferred shares.
Dividend paying stocks like Medical Properties Trust, Inc. (NYSE:MPW) tend to be popular with investors, and for good...
LifePoint was one of Middle Tennessee’s largest publicly traded health care companies until it was sold last year to Apollo Global Management for $5.6 billion.
Medical Properties Trust, Inc. (the “Company”) (MPW) announced today that it has priced an underwritten public offering of 50,000,000 shares of its common stock at a public offering price of $18.50 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 7,500,000 shares of its common stock. The Company estimates that the net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses, will be approximately $892 million, or approximately $1.0 billion if the underwriters’ option to purchase additional shares is exercised in full.
Medical Properties Trust Inc. (NYSE: MPW) has entered into a definitive agreement with the Brentwood, Tennessee-based LifePoint Health Inc. to acquire the real estate assets for 10 acute care hospitals in six states. The aggregate purchase price is $700 million and the facilities will be leased back to LifePoint, which is a portfolio company with certain funds managed by the New York City-based Apollo Global Management Inc. The deal is the latest in a series of notable acquisitions by Medical Properties Trust, which is one of Birmingham's most successful publicly traded companies. “This immediately and strongly accretive acquisition of well-run facilities from sophisticated operators and owners demonstrates the expanding market for hospital real estate,” said Edward Aldag chairman, president and CEO of MPT.
Medical Properties Trust, Inc. (the “Company”) (MPW) announced today that it has commenced an underwritten public offering to sell 50,000,000 shares of its common stock. The Company intends to grant the underwriters in the offering a 30-day option to purchase up to an additional 7,500,000 shares of its common stock. The Company intends to use the net proceeds from the offering to fund, in part, the cash purchase price for the acquisition of a portfolio of 10 acute care hospitals owned and operated by LifePoint Health, Inc. for a combined purchase price of approximately $700.0 million.
Medical Properties Trust, Inc. (“MPT” or the “Company”) (MPW) today announced that it has entered into a definitive agreement with affiliates of LifePoint Health, Inc. (“LifePoint”), one of the largest acute care operators in the United States, under which MPT will acquire the real estate assets of 10 acute care hospitals in six U.S. states for an aggregate purchase price of $700 million and will lease the facilities back to LifePoint. LifePoint is a portfolio company of certain funds managed by affiliates of Apollo Global Management, Inc., a leading global alternative investment manager.
Medical Properties (MPW) delivered FFO and revenue surprises of 3.13% and 9.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Apple Hospitality REIT's (APLE) Q3 results likely to reflect impact of softer inbound international travel demand and cost pressures across the lodging industry.
Capital improvements at City Office REIT's (CIO) properties expected to have helped the company witness occupancy gains and higher rents in Q3.
While Medical Properties' (MPW) Q3 earnings will reflect benefits from the company's acquisition-driven growth strategy, its bottom line might display a year-on-year decline.
Medical Properties Trust, Inc. today announced it will host a conference call and webcast on Thursday, October 31, 2019 at 11:00 a.m. Eastern Time to discuss the company’s third quarter 2019 financial results.
The Zacks Analyst Blog Highlights: Medical Properties Trust, Stag Industrial, Realty Income and Digital Realty Trust
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...